We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.25 | 9.00 | 9.50 | 9.25 | 9.25 | 9.25 | 59,297 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/5/2017 16:11 | New questions over armed robber’s funding Marcus Leroux July 28 2015, 1:01am, The Times An oil company chairman who concealed his underworld past by changing his name has links to a northern businessman that raise questions over his source of funding. The Times reported yesterday that Daniel Levi, who as David Hopkins had served two prison sentences, failed to disclose his criminal record to the shareholders of Sefton Resources, in breach of London Stock Exchange rules. Levi made a name for himself sharing tips and gossip about small-cap companies through his website, GuerillaInvesting.co | incanus | |
06/5/2017 12:41 | perhaps but as an investor the next 12 trading days are not as important as the next 12 months. | onedayrodders | |
05/5/2017 22:31 | Rodders,You may well be correct but i do wonder if the deal sizes are a little too large to be PI's jumping ship and bearing their losses?If it is PI's jumping ship IMO this could still go a lot lower? | tightfist | |
05/5/2017 14:08 | If we follow a similar trend as the OPTI IPO the share price should rise and settle at around 21-22p on the first raft of clinical trials news....that would represent a great start for the stock imo. It may be expected that the share price will create a step up rising channel fairly soon as news rolls out. | ibug | |
05/5/2017 13:59 | Look back at OPTI listing date... first RNS one month after listing.. a contract announcement. One month today since SBTX listed. My hunch is news on the human skin studies next week! Conjecture on my part but very common for news soon after a company IPO's | trotterstrading | |
05/5/2017 12:23 | tightfist .. I think the flippers are well gone hence the drop to where we are now which is now in the final lemming retail investor stage. | onedayrodders | |
05/5/2017 12:22 | larva 5 May '17 - 12:13 - 241 of 242 0 0 (Filtered) | onedayrodders | |
05/5/2017 12:21 | Nice analysis larva ... I see your limited to one liners only which explains a lot larva - 03 May 2017 - 10:43:08 - 14 of 18 The serious business of cybersecurity - OSI gloing to 80p larva - 03 May 2017 - 10:04:30 - 733 of 738 Countrywide 2015 with charts - CWD tanking :O) | onedayrodders | |
05/5/2017 12:13 | TIMBERRRR! 3p coming | larva | |
05/5/2017 11:44 | Rodders,The fortunate IPO participants/flipper | tightfist | |
05/5/2017 11:29 | moneytree .. not sure I agree with that as OPTI and SBTX will both be competing in markets against other products but using unique science which will separate them from everyone. Bought more today here off the impatient who think shares are like buying an overnight winning lottery ticket. thanks | onedayrodders | |
05/5/2017 10:00 | you know this could be bigger than OPTI. OPTI's market is flooded with similar products whereas skincare seems quite a new line. Just needs a damn good ramp by the BOD again.which is possible given their form. | moneytree1 | |
05/5/2017 08:11 | Looks like this could drop below IPO. | talkingtrade | |
04/5/2017 22:30 | Trotter - I'm very positive for the future of SBTX, I'm just cautious of expecting too much in the short term. You're of course correct, SOH is very excited about SBTX prospects and correct again, he expects similar share price behaviour to OPTI. My only negative is Seneca. It really annoyed me when I learned they had over 14%. They will flip and I made this point to SOH. Once they have finished flipping SBTX will settle down and then I will be a more aggressive buyer. I had a nibble at the IPO and bought a few more this week bringing my average to 11.56p. Small beer compared to my OPTI holding. | elrico | |
04/5/2017 20:06 | El, it's ok to be positive mate. :-)Speaking to the big man at the Investors night he was confident SBTX could do an OPTI (with all the usual caveats as course) | trotterstrading | |
04/5/2017 12:20 | Like OPTI news-flow lit the fire! I'm a fan of both companies and here for the long term and I don't mean a few months. The overuse of the word "imminent" and too high expectation of its impact is a concern for me. You should know what I mean, you have been invested in OPTI for long enough, Trotters. | elrico | |
04/5/2017 11:00 | I think you are underestimating the impact of imminent newsflow. Completion, and results of the human skin studies should light a fire under the share price IMHO. | trotterstrading | |
04/5/2017 09:52 | Read my comments again. I did not say I didn't there would be no news-flow. Of course there will be news on several fronts, I should imagine. My concern is some are in danger of expecting too much too soon. Tightfist is focussed on the key period which is a more realistic game-changing event, which could arrive sooner if SOH was the CEO. He like to over deliver, not that Mr Market has noticed it would appear. We have a CEO now, so let's allow her to do her job without too much expectations on price sensitive news. | elrico | |
04/5/2017 07:54 | you think they would have listed this without any planned newsflow? really?thats not how AIM works. | moneytree1 | |
04/5/2017 02:21 | saving blushes doesnt sound like me elrico. I couldnt remember and couldnt be bothered to check. Seems your point about a jv deal needing to be in place has been validated though. | slartybartfaster | |
03/5/2017 23:49 | Slarty - You may be attempting to save my blushes in post 223. I stated SBTX needed to have commercial news to support the IPO, without it any there was a risk the market would not see value in the near term to support the share price It is very early and very premature to right-off any possible news that would merit a rebound back to the high point. I don't think we will get any encouraging news any time soon. The prospectus did not suggest this, it favoured YE 2018 as far as commercial news is concerned, and it this this I feel we need. We have seen plenty of very encouraging JV partnerships news with OPTI, yet thus far, 2016/17 may as well have been written off as far as Mr Market is concerned. Why would SBTX be any different. Don't misunderstand me, I am very encouraged for the long term investment potential of SBTX. I know Cath and SOH is very excited for its prospects. However, we need to be realistic, patient and not fall into the same "imminent" news expected as has been the case with OPTI these past 18 months or so. | elrico | |
03/5/2017 20:22 | opodio3 May '17 - 19:59 - 225 of 226 0 0 (Filtered) | onedayrodders | |
03/5/2017 20:06 | Again - NO !!!¬!! | whl2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions